{"name":"TG Therapeutics, Inc.","slug":"tg-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-12-01","label":"BRIUMVI Phase 3 readout (Relapsing Multiple Sclerosis)","drug":"BRIUMVI","drugSlug":"ublituximab-xiiy","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-10-01","label":"BRIUMVI Phase 3 readout (Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis)","drug":"BRIUMVI","drugSlug":"ublituximab-xiiy","type":"phase3_readout","sentiment":"neutral"},{"date":"2033-06-30","label":"BRIUMVI Phase 2 readout (Relapsing Multiple Sclerosis)","drug":"BRIUMVI","drugSlug":"ublituximab-xiiy","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BRIUMVI","genericName":"UBLITUXIMAB-XIIY","slug":"ublituximab-xiiy","indication":"Relapsing forms of multiple sclerosis","status":"marketed"}]}],"pipeline":[{"name":"BRIUMVI","genericName":"UBLITUXIMAB-XIIY","slug":"ublituximab-xiiy","phase":"marketed","mechanism":"B-lymphocyte antigen CD20","indications":["Relapsing forms of multiple sclerosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNU1l4NTNibzVoWk1GRTFfQklnUllielBYeDRaRThhU0R4dzl5T3l5OWZJQUZEcGZIZV8wY0RLUUZYVlBmWU5IYWxKdjA4Ukc0S1JmdUFkLWtGZldBQnBiV2ZYdEpzYm9JaDRtZGZGVWNudkdZeFhnWkFySlhSb0V5cE9KT0dGTTQ2bWJsRExqOExmMDNGUkh2Mk16TjYzQQ?oc=5","date":"2026-02-27","type":"pipeline","source":"TradingView","summary":"TG THERAPEUTICS, INC. SEC 10-K Report - TradingView","headline":"TG THERAPEUTICS, INC. SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxONDdfd29rdzFUWWhpV2hOS1VKaDdRMkQ2VnN3N3QtTFNGUTJxTzF3bFExakNzUHlpVGo4enQ5ZWh3aHNNOWhoMzZVSVNtTUwtVU5DOG5QMU0wQTN6cm13MXliWTFvRXpBaU9LTE9TUlRCbG1jbmlxZVlYZ082NGdRNk15cVNRdU1rY0Fkdg?oc=5","date":"2026-02-23","type":"earnings","source":"Yahoo Finance","summary":"TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Yahoo Finance","headline":"TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPYkx6NFZiTlV5dXhGSV9kdi1EUTJ3NVdRSUEwa0E5eFh0Qk5odHU2cUpxam9jdF9FdGxjdi1WSlJDeklNWjA1cWl0Zm9WR3R3VDFoaGFCa3ZEXzhaYkFZemdtVFJEZWpmNFZMVDUzTEkzTHktSmttcFdIVmhBdjg5Zm5aMzJ6Sm5EcVZJdXFZMGVmZDg5NDZkMFBR?oc=5","date":"2026-01-15","type":"pipeline","source":"Seeking Alpha","summary":"TG Therapeutics: The 'Exit Velocity' You Can't Ignore (Rating Upgrade) - Seeking Alpha","headline":"TG Therapeutics: The 'Exit Velocity' You Can't Ignore (Rating Upgrade)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPRHIzY2hPZl9WMTVRTEw4NEFOdHh1a3V5N1I3WkU5OGtJdlhlN3paZmJaQS1aY2lEVkNuSjJxLWtZdHVoX1NzOFdaRFEyMkVSTTBnaUxpa1FvVHVkNEttZDJFQ2c3Z0lJendIaDViV3ZnZnhZRzlISGw5Z2pUVnNpZ2RzMWstOWlLQnFhdy1HMEtDN01C?oc=5","date":"2025-12-30","type":"pipeline","source":"Seeking Alpha","summary":"TG Therapeutics: What Wall Street Isn't Telling You (NASDAQ:TGTX) - Seeking Alpha","headline":"TG Therapeutics: What Wall Street Isn't Telling You (NASDAQ:TGTX)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-29","type":"pipeline","source":"simplywall.st","summary":"Could The Market Be Wrong About TG Therapeutics, Inc. (NASDAQ:TGTX) Given Its Attractive Financial Prospects? - simplywall.st","headline":"Could The Market Be Wrong About TG Therapeutics, Inc. (NASDAQ:TGTX) Given Its Attractive Financial Prospects?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPN2Q4bUd5RWFzeTV1ZXdXRHo2aVBqd3RoRFRBeF91MUR2aWNNdWRTbkwwZ3d1cFdka0JzWTNGS01NQ3RXZVAtaG9WRnV4QnFDQWswRTdrZENyQVdXSTJxWS1EZ0tDWVVyLXhaRklQeHhUQmpsbTZaNUlCNzgteWxuSXNVZmJlMW1MRkRsODlFNFdBNDluUDZJdDZtdUZjblNzcDk2RHJxR29xZw?oc=5","date":"2025-11-04","type":"pipeline","source":"BioSpace","summary":"BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces - BioSpace","headline":"BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNVm9URHdZd1hYOGZBMjNOU0F6WUxESXNXQXdfQ1pBNUhNN0dteVMwa2V2SFRGaGp1SWZNS3lKMDFhRk5WZGtkb2RTaERCdEd0NGx6UzZIOWM0QkhhVTlQM2FoRkI1bzQ3SmUwYXM2bnNTUzgzZmNDUU01U2hGdU5wWkhqeExfSzdIRGdz?oc=5","date":"2025-11-03","type":"earnings","source":"Yahoo Finance","summary":"TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance - Yahoo Finance","headline":"TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-23","type":"pipeline","source":"simplywall.st","summary":"TG Therapeutics (NASDAQ:TGTX) Takes On Some Risk With Its Use Of Debt - simplywall.st","headline":"TG Therapeutics (NASDAQ:TGTX) Takes On Some Risk With Its Use Of Debt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQc25zOVhOUWJQUVA0VW5xR2pqY05vd0FUOXFNd2dyTGE1YU4wbVhWVHVobmktamdmUWFCQ0xiZmNHa2R1RmlxcjJwSTdvY3hFQkZIaWZZdzVUWmFoSkdvdHRiNGZqSlE1ektwN28wbmxIdkF3b29uWXIzTmlmWlR0Z1REbmR2Vmo5QWp1Z1FaOTRqNmRYOVRxZ0k2ZUhzdkEyY1pTLW83X1l1cXBTLTlaV2w5WngwMkU?oc=5","date":"2025-04-10","type":"pipeline","source":"TradingView","summary":"TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why - TradingView","headline":"TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNOHRUVDd1dVpnem5VVWRsLUhFdjByWWNxZzhLSlpjbWYyZkJrbkFBN1JUZHRfbXd6UDJXZmNEWXRiUGZJSkF0cXpIQ01aaks4cWx3LXZVU0xwakdRazBzNDJlOENXOU9TYVpPZXZORHhRbGdZSjNNanhjWlphMTE1U2hVYkpqU0ZCS01XamR4TGdTMjV0TFpfSjZjci1YSnNaWWR2b3d6VmktMEdOb1N0bkgtOVhwUi1rcEE?oc=5","date":"2024-11-04","type":"pipeline","source":"Contract Pharma","summary":"FUJIFILM Diosynth Biotechnologies to Manufacture TG Therapeutics’ MS Drug - Contract Pharma","headline":"FUJIFILM Diosynth Biotechnologies to Manufacture TG Therapeutics’ MS Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQQ0RCMUhOdGY1QnpmVURkNTdiRDE1Z0Q0cTd1b1VjcEtGVmlOeEJsUUJURGpYb284RkpGUThOWHd4X1ZQbE5uSXAydHEyNGZDU3BNOXR0d1J1eGgwWHF3RXVMVnhKUzV4djQ3WFFXYWE2UHJ2UE9yVzgwV3liSmNuSUNXVTMxeFlHb3FyWThxTQ?oc=5","date":"2023-08-01","type":"deal","source":"BioPharma Dive","summary":"TG shares tumble following licensing deal for MS drug - BioPharma Dive","headline":"TG shares tumble following licensing deal for MS drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQLTFwZm96ZFY2RGZLbU0yMzJVZjZ0SU9UQ1RacDVpVVA1MldwVXRDVE56SzlpUVc0MzhLbmo3ZVBDOGxBazVxLUVkajdtRkdZZE00QVNqZzIzN25tWWoyRlF2Sm1yaDJQMjRZdUV0S0NOZDJ0TFVCd0EyZWRhOGtVOHlXYy02TktPRFlTZTU0WXpjTE05X1g0QjRlbTdablFuRzZMVlR3Tl9WbG45QjRYYncxZlNtc2pUVVV0ZzFRbEJIV2c3Ync?oc=5","date":"2022-12-28","type":"regulatory","source":"Reuters","summary":"U.S. FDA approves TG Therapeutics' multiple sclerosis drug; shares surge - Reuters","headline":"U.S. FDA approves TG Therapeutics' multiple sclerosis drug; shares surge","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}